Antioxidative Effects of Rosuvastatin in Low-to-Moderate Cardiovascular Risk Subjects
Authors
Ana Vavlukis
Ss. Cyril and Methodius University in Skopje, Faculty of Pharmacy
Cardiovascular ICCC-Program, Research Institute Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Marija Vavlukis
Ss. Cyril and Methodius University in Skopje, Faculty of Medicine
Kristina Mladenovska
Ss. Cyril and Methodius University in Skopje, Faculty of Pharmacy
Aleksandar Dimovski
Ss. Cyril and Methodius University in Skopje, Faculty of Pharmacy
Natàlia Muñoz-García
Cardiovascular ICCC-Program, Research Institute Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Victoria de Santisteban Villaplana
Cardiovascular ICCC-Program, Research Institute Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Teresa Padro
Cardiovascular ICCC-Program, Research Institute Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Lina Badimon
Cardiovascular ICCC-Program, Research Institute Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Language: English
Page range: 65 - 75
Published on: Apr 22, 2022
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year
Keywords:
Related subjects:
© 2022 Ana Vavlukis, Marija Vavlukis, Kristina Mladenovska, Aleksandar Dimovski, Natàlia Muñoz-García, Victoria de Santisteban Villaplana, Teresa Padro, Lina Badimon, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.